T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2
出版年份 2014 全文链接
标题
T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2
作者
关键词
T-DM1, Carcinosarcoma, Trastuzumab, HER2, Trastuzumab emtansine
出版物
CLINICAL & EXPERIMENTAL METASTASIS
Volume 32, Issue 1, Pages 29-38
出版商
Springer Nature
发表日期
2014-11-14
DOI
10.1007/s10585-014-9688-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
- (2014) Daniele Cretella et al. Molecular Cancer
- Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
- (2013) Baris Boyraz et al. CURRENT MEDICAL RESEARCH AND OPINION
- HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas
- (2012) Federica Guzzo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathology of mixed Müllerian tumours
- (2011) Emanuela D’Angelo et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer
- (2011) Mark Barok et al. CANCER LETTERS
- Carcinosarcoma of the ovary: A review of the literature
- (2011) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- Clinical Implications of Pathophysiological and Demographic Covariates on the Population Pharmacokinetics of Trastuzumab Emtansine, a HER2-Targeted Antibody-Drug Conjugate, in Patients With HER2-Positive Metastatic Breast Cancer
- (2011) Manish Gupta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
- (2010) Teemu T. Junttila et al. BREAST CANCER RESEARCH AND TREATMENT
- Ovarian and Uterine Carcinosarcomas
- (2010) Gunjal Garg et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The role of HER2 in cancer therapy and targeted drug delivery
- (2010) Wanyi Tai et al. JOURNAL OF CONTROLLED RELEASE
- In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
- (2009) K El-Sahwi et al. BRITISH JOURNAL OF CANCER
- Carcinosarcoma of the Ovary
- (2009) Leigh A. Cantrell et al. OBSTETRICAL & GYNECOLOGICAL SURVEY
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Unraveling the Biologic and Clinical Complexities of HER2
- (2008) John W. Park et al. Clinical Breast Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started